Skip to content

Category: Clinical Updates

RET fusions in a small subset of advanced colorectal cancers at risk of being neglected.

Pietrantonio F1,2, Di Nicolantonio F3,4, Schrock AB5, Lee J6, Morano F1, Fuca G1, Nikolinakos P7, Drilon A8, Hechtman JF9, Christiansen J10, Gowen K5, Frampton GM5, Gasparini P11, Rossini D12, Gigliotti C3,4, Kim ST6, Prisciandaro M1, Hodgson J7, Zaniboni A13, Chiu VK14, Milione M15, Patel R10, Miller V5, Bardelli A3,4, Novara L4, Wang L16, Pupa SM11, Sozzi G11, Ross J5, Di Bartolomeo M1, Bertotti A3,4, Ali S5, Trusolino L3,4, Falcone A12, de Braud F1,2, Cremolini C12.

https://www.ncbi.nlm.nih.gov/pubmed/?term=RET+fusions+in+a+small+subset+of+advanced+colorectal+cancers+at+risk+of+being+neglected.

 

 


Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small cell lung cancer receiving 1st-line chemotherapy: a Phase 1b/randomized Phase 2 trial.

Weiss JM1, Csoszi T2, Maglakelidze M3, Hoyer RJ4, Beck JT5, Gomez MD6, Lowczak A7, Aljumaily R8, Lima CMR9, Boccia RV10, Hanna W11, Nikolinakos P12, Chiu VK13, Owonikoko TK14, Schuster SR15, Hussein MA16, Richards DA17, Sawrycki P18, Bulat I19, Hamm JT20, Hart LL21, Adler S22, Antal JM22, Lai AY22, Sorrentino JA22, Yang Z22, Malik RK22, Morris SR22, Roberts PJ22, Dragnev KH23; G1T28-02 Study Group.

 

https://www.ncbi.nlm.nih.gov/pubmed/31504118